Abstract |
Endothelin-1 (ET-1) seems to enhance the pro-fibrotic protein synthesis by skin fibroblasts and its effects are mediated by endothelin-A and B (ETA and ETB) receptors. This study aimed to investigate the effects of ETA and ETB receptor antagonists (ETARA- sitaxsentan and ETA/BRA- bosentan) on type I collagen (COL-1), fibronectin (FN) and fibrillin-1 (FBL-1) synthesis in primary cultures of skin fibroblasts from systemic sclerosis patients. Primary cultures of fibroblasts were obtained from skin biopsies of 6 female systemic sclerosis patients and were treated with ET-1 (100 nM) for 24 and 48 hrs with or without pre-treatment (1 hr) with ETARA (2 μM) or ETA/BRA (10 μM). Primary culture of human scleroderma skin fibroblasts not treated with ET-1 or ET receptor antagonists (ETARA and ETA/BRA) were used as controls. COL-1, FN and FBL-1 synthesis was evaluated by immunocytochemistry and Western blot analysis. Immunocytochemistry and Western blot analysis showed that ET-1 significantly increased COL-1 and FN synthesis at 24 and 48 hrs and FBL-1 synthesis at 48 hrs vs untreated cells. ETARA significantly contrasted the ET-1-mediated increase in COL-1 and FN at 24 hrs as well as COL-1 and FBL-1 at 48 hrs, but not FN synthesis vs ET-1-treated fibroblasts. Conversely, ETA/BRA significantly antagonized the ET-1-mediated overproduction of COL-1 and FN both at 24 and 48 hrs and the FBL-1 synthesis at 48 hrs vs ET-1-treated cells. The single ETARA treatment seems to contrast significantly the increase in COL-1 synthesis, whereas the dual ETA/BRA treatment seems active in significantly antagonizing both COL-1 and FN overproduction induced by ET-1. In conclusion, ET-1 antagonism might have positive effects in contrasting the profibrotic activity of systemic sclerosis skin fibroblasts.
|
Authors | S Soldano, P Montagna, R Brizzolara, C Ferrone, A Parodio, A Sulli, B Seriolo, B Villaggio, M Cutolo |
Journal | Reumatismo
(Reumatismo)
Vol. 64
Issue 5
Pg. 326-34
(Dec 11 2012)
ISSN: 0048-7449 [Print] Italy |
PMID | 23256109
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Collagen Type I
- Endothelin A Receptor Antagonists
- Endothelin B Receptor Antagonists
- Extracellular Matrix Proteins
- FBN1 protein, human
- Fibrillin-1
- Fibrillins
- Fibronectins
- Isoxazoles
- Microfilament Proteins
- Sulfonamides
- Thiophenes
- sitaxsentan
- Bosentan
|
Topics |
- Aged
- Bosentan
- Cells, Cultured
- Collagen Type I
(biosynthesis)
- Endothelin A Receptor Antagonists
- Endothelin B Receptor Antagonists
- Extracellular Matrix Proteins
(biosynthesis)
- Female
- Fibrillin-1
- Fibrillins
- Fibroblasts
(drug effects, metabolism)
- Fibronectins
(biosynthesis)
- Fibrosis
- Humans
- Isoxazoles
(pharmacology)
- Microfilament Proteins
(biosynthesis)
- Middle Aged
- Primary Cell Culture
- Scleroderma, Systemic
(metabolism, pathology)
- Sulfonamides
(pharmacology)
- Thiophenes
(pharmacology)
|